Concepedia

Mesut Şeker

MŞ

Statistics

Publications

57

Citations

5.5K

H-Index

22

Active since

2005

Affiliations

Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi(Current)

Bezmiâlem Vakıf Üniversitesi

Haydarpaşa Numune Eğitim ve Araştırma Hastanesi

Marmara University

Istanbul Medipol University

Mesut Şeker is an author at Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi specializing in medicine, oncology, and surgery.

ORCID

Publications per year

2005–2024

57

Publications

57

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

, , +15

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

, , +12

Hepatogastroenterology

Mesut Şeker, Derya Guler, Bala Başak Öven Ustaalıoğlu et al. · Hepatogastroenterology · 2011 · 313 citations

, , +17

The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment

Mehmet Aliustaoğlu, Bala Başak Öven Ustaalıoğlu, Volkan Konya et al. · Medical Oncology · 2009 · 132 citations

, , +11

Prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection

Mesut Şeker, Bala Başak Öven Ustaalıoğlu, Umut Kefeli et al. · Annals of Surgical Oncology · 2010 · 108 citations

, , +14

1–5 of 57